ARTICLE | Distillery Therapeutics
Cancer
March 13, 2018 5:42 PM UTC
Patient sample, cell culture and mouse studies suggest inhibiting XBP1 or its activator IRE1 could help treat MYC- or MYCN-driven cancers. In breast cancer patient tumor samples, high levels of IRE1 w...